Sex differences in adverse events in Medicare individuals  ≥ 66 years of age post glioblastoma treatment

ConclusionsSex differences for individuals, 66 years and older, diagnosed with GB exist in treatment received and adverse events developed across different treatment modalities.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research